Yarrow Bioscience Inc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $48.6M | $42.3M |
| FY2022 | $0 | $31.2M | $30.9M |
| FY2023 | $0 | $88.7M | $30.6M |
| FY2024 | $0 | $52.1M | $19.9M |
| FY2025 | $0 | $27.8M | $24.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $48.6M | $42.3M |
| FY2022 | $0 | $31.2M | $30.9M |
| FY2023 | $0 | $88.7M | $30.6M |
| FY2024 | $0 | $52.1M | $19.9M |
| FY2025 | $0 | $27.8M | $24.0M |